GRAIL presents Roger's pancreatic cancer survivor story
Roger shares how the Galleri test detected his cancer early, his treatment, and his current advocacy for multi-cancer early detection.
See the latest news and media coverage for GRAIL. We track all announcements, press releases, and industry mentions in real time, all in one place.
Multi-cancer early detection company
grail.comLast updated
In short: GRAIL expanded US availability of its Galleri test via new partnerships and secured $110 million in financing amid securities litigation.
Roger shares how the Galleri test detected his cancer early, his treatment, and his current advocacy for multi-cancer early detection.
Management presents on August 11 at 10 a.m. ET with a live webcast.
The results will be released after market close on Aug. 5, 2026, followed by a webcast and conference call.
The investment strengthens GRAIL's balance sheet and supports international expansion for Galleri.
/PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer...
Multi-cancer early detection (MCED) test company Grail (NASDAQ: GRAL) has some very high-profile backers. None other than Amazon founder Jeff Bezos and Microsoft co-founder Bill...
A securities fraud class action lawsuit has been filed on behalf of GRAIL investors after its stock plummeted 50...
GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced the closing of its...
Track GRAIL and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to GRAIL and other trending companies.